In this episode, Contributing Editor Tycel Phillips, MD, speaks with Arnon Kater, MD, of Amsterdam University Medical Center in the Netherlands. Their conversation focuses on the potential role of bispecific antibodies in managing patients with Richter transformation. 

In this episode, Michael Scott, MD, from the University of Toronto, St. Michael’s Hospital, speaks with Samuel Wilson, MD, of the University of North Carolina at Chapel Hill. Their conversation focuses on recent trials examining secondary prevention of venous thromboembolism in higher-risk patients. 

In this episode, Contributing Editor Brian Hill, MD, PhD, speaks with Meghan Thompson, MD, of Memorial Sloan Kettering Cancer Center in New York. Their conversation focuses on Continuous Versus Fixed-Duration Treatment for Frontline Chronic Lymphocytic Leukemia.

In this episode, Contributing Editor Charlotte Brierley, MD, PhD, speaks with Jacqueline Garcia, MD, assistant professor at the Dana Farber Cancer Institute and Harvard Medical School and an expert in myeloid neoplasms. Their discussion focuses on the VERONA trial and its impact on the myelodysplastic syndromes community. 

In this episode Contributing Editor Brian Hill, MD, talks with Brian Koffman, MDCM, retired family doctor and chronic lymphocytic leukemia patient. Dr. Koffman is co-founder and chief medical officer of the CLL Society. They discuss Dr. Koffman’s journey as both a physician and a patient.

In this episode, Shaji Kumar, MD, editor-in-chief of The Hematologist, and consultant in hematology at Mayo Clinic in Rochester, Minnesota, talks with Robert Negrin, MD, professor of medicine at Stanford University and president-elect of ASH. They discuss recent developments in reducing graft versus host disease in allogenic stem cell transplant. 

In this episode, Contributing Editor Samuel Wilson, MD, talks with Francis Couturaud, MD, PhD, Professor of Pulmonology at University of Brest in France. They discuss low-dose direct oral anticoagulants for extended venous thromboembolism prophylaxis.

In this episode, Contributing Editor, Lauren Pommert, MD, MS, leads a conversation with Karen Rabin, MD, PhD, pediatric oncologist at the University of California, San Francisco, and Hans Hitzler, MD, with SickKids Children's Hospital in Toronto. They discuss advances in understanding the disease biology of down syndrome associated acute leukemia. Support for this episode provided by Autolus.

In this episode, Contributing Editor Lori Muffly, MD, MS, leads a conversation with two patients — Matt and Rohan — both of whom have undergone cord blood transplants for their acute myeloid leukemia. They discuss the value of peer connection as a vital component of their leukemia and transplant journey.

In this episode, Contributing Editor Surbhi Shah, MBBS, MD, a clinician, researcher, and educator at Mayo Clinic in Phoenix, Arizona, talks with Keith McCrae, MD, director of classical hematology at the Taussig Cancer Institute and professor of molecular medicine at the Cleveland Clinic Lerner College of Medicine in Ohio. They discuss a recent paper co-authored by Dr. McCrae, “Pomalidomide for Epistaxis in Hereditary Hemorrhagic Telangiectasia.” Support for this episode provided by Autolus.